Change Control Under QbD-Designed Stability Protocols
In pharmaceutical development, change is inevitable. However, how we manage change can determine whether a product meets compliance, maintains its quality, and avoids regulatory consequences. This becomes even more crucial when operating within a Quality by Design (QbD) framework, especially during stability studies. QbD-based protocols are built on scientific rationale and risk assessment, which demands…
Read More “Change Control Under QbD-Designed Stability Protocols” »